Parag Sanghvi
Radiation Oncology · San Diego, CANPI 1801005152
Payments from drug & device makers
Across 18 payments — averaging $598.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$6K
- GT Medical Technologies, Inc$3K
- Amgen$1K
- Elekta, Inc.$137
- Novocure Inc.$80
- Boston Scientific$51
- plus $64 from 3 others
What the payments were for
- Consulting fees$6,30059%
- Speaking & faculty fees$1,20011%
- Travel & lodging$2,09019%
- Food & beverage$1,17511%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 1 | $6,300 |
| GT Medical Technologies, Inc | 10 | $2,933 |
| Amgen | 1 | $1,200 |
| Elekta, Inc. | 1 | $137 |
| Novocure Inc. | 1 | $80 |
| Boston Scientific | 1 | $51 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $26 |
| Varian Medical Systems, Inc. | 1 | $23 |
| Incyte Corporation | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LORBRENA$6,300
- GammaTile$2,681
- TEPEZZA$1,200
- FLEXITRON HDR$137
How this compares
$10,765 in reported general payments places this provider in the 85th percentile of 627 radiation oncology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lidocaine Hcl ViscousLidocaine Hcl | 19 | $279 |
| Mometasone Furoate | 12 | $150 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in San Diego
- Jyoti MayadevSan Diego$892K
- Tyler SeibertSan Diego$509K
- Andrew SharabiSan Diego$252K
- Siavash JabbariSan Diego$70K
- Todd AguileraSan Diego$45K
- Donald FullerSan Diego$37K
- Loren Mellla Jolla$10M
- Hyun KimDuarte$6M
- Megan DalyOrange$4.5M
- Percy LeeIrvine$2.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.